Hologic comments on stock dip

Mammography and bone densitometry vendor Hologic has addressed the firm's recent decline in its share price, saying on Wednesday that there have been no fundamental changes in its business. The Bedford, MA-based vendor added that its financial results are meeting expectations for its third quarter, which ends June 29.

Hologic closed at $13.24 per share, down 2.1% for the day and 13% from Friday's closing share price of $15.22. As evidence of its optimism for its future prospects in digital mammography, the company said that it has received 13 international orders for its Lorad Selenia full-field digital mammography (FFDM) system. Shipments will begin in Europe later this year for the product, which is currently being reviewed by the Food and Drug Administration.

By AuntMinnie.com staff writers
June 13, 2002

Related Reading

Agfa, Hologic join forces in digital mammo, April 2, 2002


Hologic gets clearance for FFDM system, March 19, 2002

Hologic lands HPG deal, February 28, 2002

Hologic issues secondary offering, December 17, 2001

Hologic and Siemens to form FFDM alliance, November 26, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 376
Next Page